Related Experiment Video
Updated: Jun 1, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Developmental trajectories of metabolic control among White, Black, and Hispanic youth with type 1 diabetes
Jenny T Wang1, Deborah J Wiebe, Perrin C White
1Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA.
Objective:
To examine race/ethnicity and neighborhood income differences in longitudinal patterns of deterioration in hemoglobin A1c (HbA1c) values among youth (age 10 to 18 years) with type 1 diabetes.
Study Design:
A sample of 225 youth (50.2% female), including 81 White, 81 Black, and 63 Hispanic youth with type 1 diabetes, was matched initially on age and sex. Neighborhood median family income was obtained through public census databases. Self-identified race/ethnicity and all HbA1c values (grand mean, 9.09% ± 2.02%) available in patients' medical records between age 10 and 18 years were recorded and analyzed.
Results:
Hierarchical linear modeling revealed age-related deterioration in HbA1c values that differed by race/ethnicity and income. Controlling for income, White and Hispanic youth had similar HbA1c values at the start of adolescence (age 10) and demonstrated similar rates of deterioration across adolescence. Blacks had higher initial HbA1c values compared with Whites and Hispanics, but a similar rate of deterioration. Higher neighborhood income was associated with slower deterioration in HbA1c value among White teens, but not among Hispanic or Black teens.
Conclusions:
Longitudinally, Black youth appear to experience disproportionate risks compared with White and Hispanic youth when income is statistically controlled. Neither Black nor Hispanic youth appear to benefit from living in higher-income neighborhoods.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations
Type I Diabetes I: Introduction
Type II Diabetes II: Pathophysiology
